Vista Pharmaceuticals touches the roof on receiving EIR for formulation facility at Telangana

08 Sep 2017 Evaluate

Vista Pharmaceuticals is currently trading at its upper circuit limit of Rs. 41.00, up by 1.95 points or 4.99% from its previous closing of Rs. 39.05 on the BSE.

The scrip opened at Rs. 41.00 and has touched a high and low of Rs. 41.00 and Rs. 40.50 respectively. So far 144670 shares were traded on the counter.

The BSE group 'XD' stock of face value Rs. 2 has touched a 52 week high of Rs. 47.95 on 17-Apr-2017 and a 52 week low of Rs. 15.50 on 22-Nov-2016.

Last one week high and low of the scrip stood at Rs. 41.00 and Rs. 34.10 respectively. The current market cap of the company is Rs. 109.88 crore.

The promoters holding in the company stood at 31.78 %, while Institutions and Non-Institutions held 0.43 % and 67.79 % respectively.

Vista Pharmaceuticals’ formulation facility at APIIC Industrial Estate, Nalgonda District in state of Telangana, which was inspected by US Food & Drug Administration (USFDA) during September 2016, has received Establishment Inspection Report (EIR), thereby confirming the closure of the inspection.

Vista Pharmaceuticals is engaged in manufacturing and selling of pharmaceutical, medical and veterinary preparations. The company also sells the products to its related companies, which are engaged in the manufacture of formulations.


Vista Pharma Share Price

8.69 0.00 (0.00%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×